原发性肝癌与乙型,丙型肝炎病毒感染的关系

用酶联免疫分析法（ＥＬＩＳＡ）对我院外科手术及病理检查证实的１５７例原发性肝癌（ＰＨＣ）进行乙型肝炎病毒血清感染标志（ＨＢＶＭ）及抗－ＨＣＶ检测，发现我国１３０例患者ＨＢＶＭ的阳性率为８８．５％，抗－ＨＣＶ阳性率１０．８％。２７例毕裔印尼（印尼）患者的ＨＢＶＭ及抗－ＨＣＶ阳性率分别为５９．３％及４８．１％，提示我国ＰＨＣ与ＨＢＶ感染关系密切，ＨＣＶ感染不是最主要原因。

A Study on Prevalence of Sero-markers of Hepatitis B Virus(HBVM) and Antibodies to Hepatitis C Virus(Anti-HCV) in Patients with Primary Hepatocellular Carcinoma(PHC)

The prevalence of HBV sero-markers and anti-HCV was investigated by enzyme linked immunosorbent assay(ELISA) in 157 pathologically confirmed primary hepatocellular carcinoma(PHC) cases. In 130 Chinese cases, the positive rate of HBVM and anti-HCV was 88. 5% and 10.8%, respectively, and in 27 Chinese-Indonesia cases 59.3% and 48.1%, respectively. These results suggest that the PHC is closely related to infection with hepatitis B virus(HBV), whereas infection with hepatitis C virus(HCV) is not an important causative factor of PHC in Chinese.